D.A. Davidson & Co. Nektar Therapeutics Transaction History

D.A. Davidson & Co.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 29, 2019	SELL	$30.43 - $56.65 $139,978 - $260,590	-4,600 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$23.02 - $60.5 $105,892 - $278,300	4,600 New	4,600 $275,000
Q3 2017 Nov 08, 2017	SELL	$17.79 - $24.0 $81,834 - $110,400	-4,600 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	4,600	4,600 $0

126

109M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $259M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.